Department of Otolaryngology/Head and Neck Surgery, The Johns Hopkins School of Medicine, Baltimore, MD 21231, USA.
FEBS Lett. 2013 Aug 19;587(16):2536-41. doi: 10.1016/j.febslet.2013.06.020. Epub 2013 Jul 2.
The tumor protein p63/microRNA functional network appears to play a decisive role in chemoresistance of human epithelial cancers. The cisplatin- and phosphorylated-ΔNp63α-dependent microRNAs, whose expression was varied in sensitive and resistant squamous cell carcinoma cells (SCC, which were derived from larynx and tongue tumors), were shown to modulate the expression of multiple members of cell cycle arrest, apoptosis and autophagy pathways. The specific microRNAs were further shown to modulate the resistant phenotype of SCC cells in vitro, thereby providing groundwork for novel chemotherapeutic venues for head and neck cancer.
肿瘤蛋白 p63/微 RNA 功能网络似乎在人类上皮癌的化疗耐药中起决定性作用。顺铂和磷酸化 ΔNp63α 依赖性微 RNA 的表达在敏感和耐药鳞状细胞癌细胞 (SCC,源自喉和舌肿瘤) 中有所不同,这些微 RNA 被证明可以调节细胞周期阻滞、细胞凋亡和自噬途径的多个成员的表达。进一步证明,特定的微 RNA 可以调节 SCC 细胞在体外的耐药表型,从而为头颈部癌症提供新的化疗途径的基础。